Article
Finding new cancer epigenetic and genetic biomarkers from cell-free DNA by combining SALP-seq and machine learning
1 Jan 2020
Abstract excerpt
The effective non-invasive diagnosis and prognosis are critical for cancer treatment. The plasma cell-free DNA (cfDNA) provides a good material for cancer liquid biopsy and its worth in this field is increasingly explored. Here we describe a new pipeline for effectively finding new cfDNA-based biomarkers for cancers by combining SALP-seq and machine learning. Using the pipeline, 30 cfDNA samples from 26...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
